Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Allergan's novel glaucoma drug nears clinical trials

Nov. 2, 2000

Update on Pharmacia's ocular medications

Oct. 24, 2000

Protective effect demonstrated for SKK-60060 in rat model of retinal ischemia-reperfusion

Oct. 23, 2000

Ciba Vision and QLT seek to expand Visudyne indication in the E.U.

Oct. 5, 2000

New series from Senju particularly useful for ocular disorders

Oct. 4, 2000

New ocular hypotensive agents in the Alcon pipeline

Sep. 8, 2000

New agents for glaucoma reported by Santen

Sep. 4, 2000

Visudyne sNDA granted priority review status

Sep. 1, 2000

Inspire reports synthesis of more stable P2Y2 agonists

Aug. 30, 2000

Allergan in-licenses gatifloxacin from Kyorin for treatment of ocular infections

Aug. 29, 2000

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...